GURTNER GEOFFREY C has a total of 30 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, pharmaceuticals and organic fine chemistry are SHANGHAI CLINICAL ENGINE TECH DEVELOPMENT CO LTD, JIMRO CO LTD and AMITIE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 24 | |
#2 | Australia | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Macromolecular chemistry and polymers | |
#5 | Machines | |
#6 | Measurement | |
#7 | Micro-structure and nano-technology |
# | Name | Total Patents |
---|---|---|
#1 | Gurtner Geoffrey C | 30 |
#2 | Horne Kenneth N | 11 |
#3 | Rajadas Jayakumar | 10 |
#4 | Longaker Michael T | 9 |
#5 | Saul Gordon | 7 |
#6 | Yock Paul | 6 |
#7 | Dauskardt Reinhold H | 6 |
#8 | Hoffmann Drew A | 5 |
#9 | Brownlee Michael A | 5 |
#10 | Fuller Gerald G | 3 |
Publication | Filing date | Title |
---|---|---|
US2016102288A1 | Efficient stem cell delivery into biomaterials using capillary driven encapsulation | |
US2013197358A1 | Method and device for surgical marking | |
US2011305745A1 | Pullulan regenerative matrix | |
US2010092546A1 | Topical and Transdermal Delivery of HIF-1 Modulators to Prevent and Treat Chronic Wounds | |
US2009187199A1 | Compositions and methods for joining non-conjoined lumens | |
US2010057056A1 | Methods and devices for improving the appearance of tissue | |
US2009065009A1 | Method and tools for the reduction of excess skin | |
US2008262519A1 | Compositions and methods for joining non-conjoined lumens | |
US2006281748A1 | Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux | |
US2006037091A1 | Method for producing hypertrophic scarring animal model for identification of agents for prevention and treatment of human hypertrophic scarring |